Barinthus Biotherapeutics (BRNS) Cash from Investing Activities Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -114.28% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 826.39% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -674.01% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | 1,200.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,200.00% |
| Dec 31, 2025 | 100.72% |
| Sep 30, 2025 | 495.61% |
| Jun 30, 2025 | 83.33% |
| Mar 31, 2025 | 98.38% |
| Dec 31, 2024 | -281.70% |
| Sep 30, 2024 | -216.67% |
| Jun 30, 2024 | 93.65% |
| Mar 31, 2024 | 87.71% |
| Dec 31, 2023 | 126.11% |
| Sep 30, 2023 | 98.22% |
| Jun 30, 2023 | -47.18% |
| Mar 31, 2023 | -129.58% |
| Dec 31, 2022 | 95.19% |
| Sep 30, 2022 | -1,476.56% |
| Jun 30, 2022 | -916.83% |
| Mar 31, 2022 | -178.57% |
| Dec 31, 2021 | -6,151.28% |
| Sep 30, 2021 | -326.67% |
| Jun 30, 2021 | -339.13% |